Actively Recruiting
Diagnosis, Prognosis, and Mechanisms in Panvascular Disease
Led by Jinwei Tian · Updated on 2025-09-03
1000
Participants Needed
1
Research Sites
317 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to establish a standardized cohort for panvascular diseases, encompassing biological materials such as DNA samples, along with extensive patient medical records and follow-up information. The design of this database will enable it to serve as a comprehensive resource for future medical research. Upon data collection, researchers will conduct various statistical analyses to enhance our understanding of the factors and mechanisms contributing to various panvascular diseases, including coronary heart disease, myocardial infarction, stroke, and peripheral vascular disease. These statistical analyses will also aid in identifying more effective treatment strategies for these conditions. By amassing a large volume of data from a significant number of patients with panvascular diseases, researchers will be able to perform highly precise analyses of the factors influencing the onset, progression, and treatment of these diseases. The results of these precise analyses can then be utilized to optimize clinical practices for the prevention and treatment of panvascular diseases.
CONDITIONS
Official Title
Diagnosis, Prognosis, and Mechanisms in Panvascular Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 18 to 80 years old
- Diagnosed or suspected panvascular disease with atherosclerotic lesions in two or more vascular regions (intracranial arteries, carotid arteries, coronary arteries, aorta, peripheral arteries)
- Willing to participate and provide signed informed consent
You will not qualify if you...
- Severe hemodynamic instability
- Severe cardiac dysfunction with ejection fraction less than 30%
- Severe arrhythmias
- Severe valvular heart disease
- Cardiomyopathy caused by non-coronary artery diseases
- Non-atherosclerotic coronary artery disease (such as artery dissection or embolism)
- Severe non-cardiovascular diseases
- Women who are pregnant or breastfeeding
- Individuals refusing to provide signed informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Harbin Medical University
Harbin, Heilongjiang, China, 150086
Actively Recruiting
Research Team
T
Tian J Jinwei Tian, MD, PhD
CONTACT
W
Wang Y Yan Wang, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here